Millions of Eye Drops Recalled Over Sterility Concerns

A significant recall has been issued for over 3.1 million bottles of lubricating eye drops by K.C. Pharmaceuticals. The recall, initiated on March 3, 2026, stems from the company's failure to adequately test and prove the sterility of its products. These eye drops are distributed under numerous brand names across major retail chains nationwide.

The potential consequences of using non-sterile eye drops are severe, including serious eye infections. Bacteria and fungi in contaminated drops can be difficult for the immune system to combat on the eyeball. This is not the first instance of sterility issues in the eye drop market, and it marks the second time since 2023 that the Food and Drug Administration has flagged sterility problems at K.C. Pharmaceuticals.

Eight specific products are affected by this recall, including Dry Eye Relief, Artificial Tears, and Sterile Eye Drops variants, sold under brands like Top Care, Walgreens, CVS, and Kroger. Expiration dates range from April 30, 2026, to October 31, 2026. Consumers can verify affected lot numbers and expiration dates on the FDA website.

As of early April 2026, no infections linked to these recalled eye drops have been reported. However, individuals experiencing symptoms such as eye redness, discharge, vision changes, or pain after using these products should seek medical attention and report to the FDA. Previous outbreaks of severe eye infections linked to contaminated eye drops have resulted in vision loss, removed eyeballs, and even fatalities.